Retrospective Study of Patient Surveys
NCT04199806 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2019-12-16
Summary
To collect data from Allergan Patient Surveys (patient surveys) and Allergan Patient Information Form (patient information form) to describe:
1. Patient demographics
2. Treatment patterns
3. Patient feedback and overall experience with MMS treatment
Conditions
- Body Fat Disorder
Interventions
- OTHER
-
Questionnaire review
Review data from questionnaires received about MMS experience.
Sponsors & Collaborators
-
Zeltiq Aesthetics
lead INDUSTRY
Principal Investigators
-
Kerrie Jiang, NP · Zeltiq Aesthetics
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 22 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-11-22
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
More Related Trials
-
Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea
NCT03691415 ·Status: TERMINATED
-
Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
NCT06585462 ·Status: RECRUITING ·Phase: PHASE1
-
An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
NCT00109148 ·Status: COMPLETED ·Phase: PHASE2
-
Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity
NCT04199351 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects
NCT00148382 ·Status: COMPLETED ·Phase: PHASE1
-
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202
NCT02483533 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
NCT04144049 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)
NCT00482638 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients
NCT05197556 ·Status: COMPLETED ·Phase: PHASE2
-
Aleniglipron Phase 2 Body Composition Study
NCT07169942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
NCT01968720 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
NCT05195112 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533481 ·Status: COMPLETED ·Phase: PHASE2
-
Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity
NCT05834062 ·Status: WITHDRAWN ·Phase: PHASE2
-
An Open-label Study That Will Test a Second Treatment Session of RZL-012.
NCT05763160 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
NCT01719419 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Feasibility Study of XAF5 Gel for Reduction of Submental Fat
NCT01990326 ·Status: SUSPENDED ·Phase: PHASE2
-
A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)
NCT00533598 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of LLF580 in Obese Volunteers
NCT03466203 ·Status: COMPLETED ·Phase: PHASE1
-
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients
NCT00483171 ·Status: TERMINATED ·Phase: PHASE3
-
Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study
NCT01032889 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events
NCT05476679 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
NCT06886126 ·Status: RECRUITING ·Phase: PHASE2
-
An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects
NCT01666691 ·Status: COMPLETED ·Phase: PHASE2